Corrigendum: Ex vivo modulation of intact tumor fragments with anti-PD-1 and anti-CTLA-4 influences the expansion and specificity of tumor-infiltrating lymphocytes
Thomas Morgan Hulen, Christina Friese, Nikolaj Pagh Kristensen, Joachim Stoltenborg Granhøj, Troels Holz Borch, Marlies J. W. Peeters, Marco Donia, Mads Hald Andersen, Sine Reker Hadrup, Inge Marie Svane, Özcan Met
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCancer Immunotherapy and Biomarkers · Immune cells in cancer · Ferroptosis and cancer prognosis
In the published article, there was an error in Figure 4 as published. Antigen category of “Overexpressed Antigens” was mislabeled. The corrected Figure 4 and its caption appear below.
In the published article, there was also an error in Table 2 as published. Column heading of “%CD8+ of CD3+” was mislabeled and English decimal, “.” was not used. The corrected Table 2 and its caption appear below.
The authors apologize for these errors and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.